ProShares UltraShort Nasdaq Biotechnology (BIS) Chart & Stock Price History $16.07 +0.18 (+1.13%) (As of 10:54 AM ET) Add Compare Share Share Chart Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipShort InterestTrends ProShares UltraShort Nasdaq Biotechnology Stock Price Performance 5 Day Performance+1.64%1 Month Performance+3.41%3 Month Performance+7.28%6 Month Performance-7.27%Year-To-Date Performance-11.07%1 Year Performance-29.24% Receive BIS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Election warning coming true… (Ad)If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. BIS Stock Chart for Tuesday, December, 3, 2024 BIS Chart by TradingView ProShares UltraShort Nasdaq Biotechnology Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/02/2024$15.83$15.89+0.38%$15.98$15.823,101 shs$3.50 million11/29/2024$15.81$15.83+0.13%$15.87$15.777,255 shs$3.48 million11/28/2024$15.81$15.81$16.00$15.801,759 shs$3.48 million11/27/2024$16.15$15.81-2.11%$16.00$15.801,759 shs$3.48 million11/26/2024$16.18$16.15-0.19%$16.66$16.1515,594 shs$3.55 million11/25/2024$16.67$16.18-2.94%$16.24$15.9617,471 shs$3.56 million Get the Latest News and Ratings for BIS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 11/22/2024$17.14$16.67-2.75%$17.03$16.5112,155 shs$3.67 million11/21/2024$17.42$17.14-1.60%$17.50$17.0010,779 shs$3.77 million11/20/2024$17.66$17.42-1.36%$17.68$17.3926,947 shs$3.83 million11/19/2024$17.77$17.66-0.62%$18.01$17.6314,708 shs$3.89 million11/18/2024$17.68$17.77+0.51%$17.91$17.6219,883 shs$3.91 million11/15/2024$16.22$17.68+9.00%$17.70$16.4544,468 shs$3.89 million11/14/2024$15.48$16.22+4.78%$16.23$15.768,250 shs$3.57 million11/13/2024$15.24$15.48+1.57%$15.48$14.9313,063 shs$3.41 million11/12/2024$14.43$15.24+5.61%$15.24$14.566,135 shs$3.35 million11/11/2024$14.35$14.43+0.56%$14.43$14.1016,747 shs$3.18 million11/08/2024$14.54$14.35-1.31%$14.42$14.333,251 shs$3.16 million11/07/2024$14.92$14.54-2.55%$14.76$14.4622,640 shs$3.20 million11/06/2024$15.19$14.92-1.78%$15.11$14.7123,949 shs$3.28 million11/05/2024$15.50$15.19-2.00%$15.65$15.1817,284 shs$3.34 million11/04/2024$15.54$15.50-0.26%$15.76$15.3910,633 shs$3.41 million Related Companies JPMorgan Healthcare Leaders ETF Stock Chart Horizon Kinetics Medical ETF Stock Chart First Trust Nasdaq Pharmaceuticals ETF Stock Chart Invesco Nasdaq Biotechnology ETF Stock Chart F/m Emerald Life Sciences Innovation ETF Stock Chart ProShares Ultra Nasdaq Biotechnology Stock Chart Invesco Dorsey Wright Healthcare Momentum ETF Stock Chart Invesco S&P SmallCap Health Care ETF Stock Chart VanEck Biotech ETF Stock Chart VanEck Pharmaceutical ETF Stock Chart Receive BIS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIS) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
